These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 3864775

  • 21. [Effect ofloxacin on Haemophilus influenza, Streptococcus pneumoniae and Neisseria meningitidis. Comparison with similar molecules].
    Dabernat H, Delmas C, Lareng MB.
    Pathol Biol (Paris); 1985 May; 33(5):385-8. PubMed ID: 3162140
    [Abstract] [Full Text] [Related]

  • 22. Comparative in vitro activities of ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin against Bacteroides fragilis and Clostridium difficile.
    Edlund C, Nord CE.
    Scand J Infect Dis; 1986 May; 18(2):149-51. PubMed ID: 2939556
    [Abstract] [Full Text] [Related]

  • 23. In vitro activity of the new 4-quinolone compound Ro 23-6240.
    Clarke AM, Zemcov SJ.
    Eur J Clin Microbiol; 1987 Apr; 6(2):161-4. PubMed ID: 3109895
    [Abstract] [Full Text] [Related]

  • 24. Antibacterial activity of ofloxacin and its mode of action.
    Sato K, Inoue Y, Fujii T, Aoyama H, Mitsuhashi S.
    Infection; 1986 Apr; 14 Suppl 4():S226-30. PubMed ID: 3028966
    [Abstract] [Full Text] [Related]

  • 25. In vitro and in vivo activity of DL-8280, a new oxazine derivative.
    Sato K, Matsuura Y, Inoue M, Une T, Osada Y, Ogawa H, Mitsuhashi S.
    Antimicrob Agents Chemother; 1982 Oct; 22(4):548-53. PubMed ID: 6960805
    [Abstract] [Full Text] [Related]

  • 26. In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin.
    Van der Auwera P.
    Infection; 1986 Oct; 14(3):142-4. PubMed ID: 2942489
    [Abstract] [Full Text] [Related]

  • 27. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R, Cellini L, Allocati N, Di Girolamo A, Selan L, Scazzocchio F.
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [Abstract] [Full Text] [Related]

  • 28. [Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
    Joly-Guillou ML, Bergogne-Berezin E.
    Pathol Biol (Paris); 1985 May; 33(5):416-20. PubMed ID: 3162142
    [Abstract] [Full Text] [Related]

  • 29. In-vitro activity of pefloxacin compared with six other quinolones.
    Ligtvoet EE, Wickerhoff-Minoggio T.
    J Antimicrob Chemother; 1985 Oct; 16(4):485-90. PubMed ID: 3864776
    [Abstract] [Full Text] [Related]

  • 30. [Dependence of the bactericidal activity and mutant selection of 4-quinolones on their serum concentration levels].
    Bauernfeind A, Petermüller C, Heinrich B, Gablac R.
    Infection; 1986 Oct; 14 Suppl 1():S26-30. PubMed ID: 3082765
    [Abstract] [Full Text] [Related]

  • 31. Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.
    Cullmann W, Stieglitz M, Baars B, Opferkuch W.
    Chemotherapy; 1985 Oct; 31(1):19-28. PubMed ID: 3156025
    [Abstract] [Full Text] [Related]

  • 32. In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative.
    Hirai K, Aoyama H, Hosaka M, Oomori Y, Niwata Y, Suzue S, Irikura T.
    Antimicrob Agents Chemother; 1986 Jun; 29(6):1059-66. PubMed ID: 2942103
    [Abstract] [Full Text] [Related]

  • 33. [Antibacterial activity of norfloxacin, ofloxacin and ciprofloxacin according to resistance phenotypes to nalidixic acid and pefloxacin].
    Soussy CJ, Le Van Thoi J, Duval J.
    Pathol Biol (Paris); 1990 May; 38(5):376-84. PubMed ID: 2367152
    [Abstract] [Full Text] [Related]

  • 34. In vitro evaluation of A-56619 and A-56620, two new quinolones.
    Barry AL, Thornsberry C, Jones RN.
    Antimicrob Agents Chemother; 1986 Jan; 29(1):40-3. PubMed ID: 2942099
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Sensitivity of obligate anaerobes to ofloxacin, pefloxacin, enoxacin and norfloxacin].
    Dubreuil L, Devos J, Romond C, Bryskier A.
    Pathol Biol (Paris); 1985 May; 33(5):421-5. PubMed ID: 3162143
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
    Zuccarelli M, Simeon de Buochberg M, Maillols M, Armynot du Chatelet AM, Attisso MA.
    Pathol Biol (Paris); 1988 May; 36(5):403-9. PubMed ID: 3136422
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.